Drugs / Nozin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04060849 | Sep 2019 → Apr 2020 | cancer, hematopoietic and lymphoid cell neoplasm | Fred Hutchinson Cancer Center | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06210594 | Apr 2024 → Nov 2025 | staphylococcus aureus infection | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nozin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04060849 ↗ |
| Route | Intranasal | “Given via nasal single-use popswabs or single-use cotton tipped applicators” NCT04060849 ↗ |